title: Prognostic signature of ALL blasts at diagnosis: what can we really find?
authors.forename: Virginie
authors.initials: V
authors.lastname: Gandemer
authors.forename: Marie
authors.initials: M
authors.lastname: de Tayrac
authors.forename: Jean
authors.initials: J
authors.lastname: Mosser
authors.forename: Marie Dominique
authors.initials: MD
authors.lastname: Galibert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001752:Blast Crisis / Q000473:pathology*; D019295:Computational Biology; D020869:Gene Expression Profiling; D006801:Humans; D015448:Leukemia, B-Cell / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D018655:Lymphocyte Count; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D011379:Prognosis; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor